Home » Newsletters » BioWorld

BioWorld

Feb. 4, 1993

View Archived Issues

HEMACARE UPDATES AIDS TRIAL DATA

PRIZM LICENSES DIAGNOSTIC TECHNOLOGY

UNITED BIOMEDICAL FILES FOR IPO

EUROPEAN PATENT FOR AIDS VACCINE

NEW TECHNIQUE TO TARGET CANCER CELLS

BILL WOULD CLARIFY PROCESS PATENTS

OSTEOPOROSIS TRIAL ANALYSIS CONTINUES

TRADE GROUP ANNOINTS NEW PRESIDENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....